Elite Pharma Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2023 | 03-2022 | 03-2021 | 03-2020 | 03-2019 | |
| Sales | 34,155 | 32,262 | 25,381 | 17,995 | 7,569 |
| Cost of Goods | 17,561 | 17,467 | 13,514 | 10,016 | 4,701 |
| Gross Profit | 16,594 | 14,795 | 11,867 | 7,979 | 2,868 |
| Operating Expenses | 13,479 | 10,191 | 10,276 | 10,280 | 12,727 |
| Operating Income | 3,676 | 5,071 | 2,105 | -2,285 | -9,159 |
| Interest Expense | 1,113 | 192 | 260 | 356 | 369 |
| Other Income | 1,423 | 1,426 | 2,300 | 403 | -427 |
| Pre-tax Income | 3,986 | 6,304 | 4,145 | -2,238 | -9,955 |
| Income Tax | 424 | -1,736 | N/A | 2 | -676 |
| Net Income Continuous | 3,562 | 8,898 | 5,088 | -2,240 | -9,279 |
| Net Income | $3,562 | $8,898 | $5,088 | $-2,240 | $-9,279 |
| EPS Basic Total Ops | 0.00 | 0.01 | 0.01 | 0.00 | -0.01 |
| EPS Basic Continuous Ops | 0.00 | 0.01 | 0.01 | 0.00 | -0.01 |
| EPS Diluted Total Ops | 0.00 | 0.01 | 0.00 | 0.00 | -0.01 |
| EPS Diluted Continuous Ops | 0.00 | 0.01 | 0.01 | 0.00 | -0.01 |
| EPS Diluted Before Non-Recurring Items | 0.00 | 0.01 | 0.01 | 0.00 | -0.01 |
| EBITDA(a) | $5,021 | $6,505 | $3,629 | $-775 | $-7,902 |